Orthofix Medical (OFIX) Income from Continuing Operations (2010 - 2026)

Orthofix Medical has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 20908000.0 for Q1 2026.

• Quarterly Income from Continuing Operations rose 60.62% year-over-year to 20908000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33267000.0 (up 123.25% YoY) and the FY2025 annual result came in at 1081000.0, up 100.86% from the prior year.
• Income from Continuing Operations retreated to 20908000.0 in Q1 2026, from 91051000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 132620000.0 in Q4 2023 and troughed at 60938000.0 in Q1 2023.
• A 5-year average of 9539647.06 and a median of 22795000.0 in 2025 frame the typical range for Income from Continuing Operations.
• Biggest YoY gain for Income from Continuing Operations was 1977.94% in 2023; the steepest drop was 1684.01% in 2023.
• Tracing OFIX's Income from Continuing Operations over 5 years: stood at 7062000.0 in 2022, then soared by 1977.94% to 132620000.0 in 2023, then slumped by 121.98% to 29146000.0 in 2024, then soared by 412.4% to 91051000.0 in 2025, then plunged by 122.96% to 20908000.0 in 2026.
• Business Quant data shows OFIX's Income from Continuing Operations at 20908000.0 in Q1 2026, 91051000.0 in Q4 2025, and 22795000.0 in Q3 2025.